|Articles|November 20, 2013

Special Reports

  • Immunotherapy (Issue 1)
  • Volume 1
  • Issue 1

PD-1 and PD-L1 Antibodies in Lung Cancer

Naiyer A. Rizvi, MD, an associate attending physician, Memorial Sloan-Kettering Cancer Center, discusses PD-1 and PD-L1 antibodies in development for the treatment of lung cancer.

Naiyer A. Rizvi, MD, an associate attending physician, Memorial Sloan-Kettering Cancer Center, discusses PD-1 and PD-L1 antibodies in development for the treatment of lung cancer.

Read about predictive biomarkers ofPD-1 pathway blockade


Latest CME